Copenhagen, Denmark
Onsite/Online

ESTRO 2022

Session Item

Monday
May 09
09:00 - 10:00
Poster Station 1
17: Treatment planning
Christoph Schneider, The Netherlands
3160
Poster Discussion
Physics
Planning MV photons with dose-to-medium can be disruptive to traditional planning
Diego Juado-Bruggeman, Spain
PD-0735

Abstract

Planning MV photons with dose-to-medium can be disruptive to traditional planning
Authors:

Diego Jurado-Bruggeman1, Carles Muñoz-Montplet1

1Institut Català d’Oncologia - Girona, Medical Physics and Radiation Protection Department, Girona, Spain

Show Affiliations
Purpose or Objective

Planning considerations were developed for previous generation calculation algorithms yielding dose to water-in-water (Dw,w). Advanced algorithms offer superior radiation transport accuracy, but their dose values in terms of dose to medium-in-medium (Dm,m) depend on the medium considered. This can be problematic in plan optimisation since a uniform photon fluence does not necessarily imply a uniform dose distribution. This work aims to show how trying to mimic traditional Dw,w planning with Dm,m can involve new clinical and robustness issues.

Material and Methods

A head and neck case was considered for illustration. It involved air, bone, teeth, and implants outside the CTV. Accelerated simultaneous boost was delivered to three PTVs (54, 60, and 70 Gy) in 33 fractions using VMAT technique. For simplicity, we focused on PTV70Gy and the mandible as organ-at-risk (OAR). Acuros XB and AAA algorithms were used to obtain Dm,m and Dw,w distributions, respectively. First, a plan was optimised to deliver uniform photon fluence to the PTV -as in Dw,w planning- and calculated with Dm,m. Second, another plan was optimised to achieve uniform Dm,m. It was recalculated in Dw,w to analyse the clinical differences with previous practice. Additionally, robustness was evaluated.

Results

Figure 1 shows the results of both planning strategies. Uniform fluence produced cold spots in bone and implants. Uniform Dm,m compensated them by locally increasing fluence, resulting in higher doses beyond Dw,w acceptability criteria.


Figure 2 shows the differences between homogeneous Dm,m and Dw,w. Doses were 1% higher for the target (muscle CTV), and up to +4% for the mandible, thus increasing toxicity risk. Robustness was impaired when the fluence increases and the heterogeneities did not match.


Conclusion

Planning with Dm,m as with Dw,w can be disruptive.

There are systematic differences in dose prescription and constraints. For water-like tissues, 1% water/muscle difference is addressed in AAPM TG329. For bony tissues, either specific Dm,m constraints should be used, or the different Dm,m response should be switched off by recalculating in Dw,w or, more accurately, dose to reference-like medium (Dref,m*).

Forcing homogeneous Dm,m distributions can introduce local fluence increases, deviating from previous practice. They increase NTCP if found in an OAR and impair robustness if their position mismatches the heterogeneity. Improving robustness implies using more homogeneous fluences while sacrificing PTV Dm,m homogeneity. Hence, Dm,m robust optimisation should be implemented.

Homogeneous photon fluences resemble previous practice but can result in inhomogeneous Dm,m distributions difficult to evaluate. ICRU criteria should be adapted for target homogeneity, minimum, etc Alternatively, distributions can be recalculated in terms of Dw,w or Dref,m*.

These issues should be considered in guidelines for Dm,m planning and evaluation, especially when consistency is critical, as in clinical trials and planning automation.